|
The device was not returned to stryker sustainability solutions for evaluation.The facility sent the device to sterilmed for reprocessing.As the device was not returned for evaluation, inspection was unable to be performed.A review of the dhr could not be performed as the lot/serial number was not reported.The reported event could be attributed to damage to the identification label on the plug due to handling conditions.The instructions for use (ifu) state: - the lf1637 instrument is intended for use only with the covidien forcetriad energy platform.Use of this instrument with other covidien generators or with generators produced by other manufacturers may not result in the desired tissue effect, may result in injury to the patient, or surgical team, or may cause damage to the instrument.- these instruments are only intended for use by individuals with adequate training and familiarity with the specific procedure being undertaken.Use of this equipment without such training may result in serious unintended patient injury.For further information about techniques, complications and hazards, consult the medical literature.- before beginning the procedure, verify overall compatibility of all instruments and accessories.- insert the connector into the receptacle on the generator.Follow the instructions in the generator user¿s guide to complete the setup procedure.- inspect the instrument for overall condition and physical integrity.Do not use the instrument if any damage is noted.Return the instrument and packaging to stryker if it is not in acceptable condition for the procedure.- examine all ligasure system and instrument connections before using.Improper connection may result in arcing, sparks, accessory malfunction, or unintended surgical effects.- inspect the instrument and cords for breaks, cracks, nicks, or other damage before use.Failure to observe this caution may result in injury or electrical shock to the patient or surgical team or cause damage to the instrument.If damaged, do not use.The reported event will continue to be monitored through post-market surveillance.(b)(4).
|